Author: oncologs.com

CHICAGO — Men with prostate cancer who are treated with radiation therapy experience significant side effects such as fatigue, sleep problems, anxiety and depressive symptoms. But listening to mindfulness audio recordings significantly eased those symptoms, a new Northwestern Medicine study has found.  Credit: Northwestern University It’s a ‘twofer’:

IBD is a common chronic gastrointestinal disorder and current treatment strategies can cause adverse effects. Thus, there is a need to identify alternative compounds to treat IBD. Similarly, the dose-related toxicity and efficacy of anticancer drugs needs to be monitored accurately to improve the treatment

Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an inherent risk of serious bleeding due to trauma or unforeseen events. A team from the University of Geneva (UNIGE) and the University of Sydney

Leuven (Belgium) 30/04/2024 – For the first time, researchers from VIB-KU Leuven, UZ Leuven, Janssen Pharmaceutica and multiple international collaborators have introduced quantitative methods and extensive confounder control to discover microbiome biomarkers in colorectal cancer development. While multiple microbial taxa have been put forward as potential

Huntsman Cancer Institute at the University of Utah (the U) received the Vineyard Cares Business of the Year Award. This award, given by Vineyard as part of the Impact Vineyard Awards, honors businesses that have made significant contributions to the community. Credit: Huntsman Cancer Institute Huntsman Cancer Institute

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat the disease. Kaposi sarcoma is a cancer that is the most common cancer

Oncotarget is a contributing sponsor at the 19th International p53 Workshop in Trieste, Italy, on May 13–16, 2024. Credit: Impact Jouranls Oncotarget is a contributing sponsor at the 19th International p53 Workshop in Trieste, Italy, on May 13–16, 2024. BUFFALO, NY- April 29, 2024 –

Medium-sized dogs have a higher risk of developing cancer than the very largest or smallest breeds, according to a UC Riverside study.  Credit: Petful.com Medium-sized dogs have a higher risk of developing cancer than the very largest or smallest breeds, according to a UC Riverside

HOUSTON and ALBUQUERQUE, N.M. ― A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health

New York, NY [April 29, 2024]—Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. The appointment reaffirms Icahn Mount Sinai’s commitment to pioneering medical progress and catalyzing the